Semaglutide

A GLP‑1 receptor agonist with proven ASCVD benefit and strong weight loss is a great candidate drug for patients with cardiovascular disease and obesity. However, it is preferred for HFpEF and it has not been shown to reduce HFrEF hospitalization. It may be added later for weight or ASCVD risk, but it does not replace another cardioprotective drug for HF benefit as a first step.

  • Starts smoking again [undo]
  • How do scientists measure brain changes? [undo]
  • Interphase, prophase, metaphase, anaphase, telophase [undo]
  • Opción 3 [undo]
  • Ξεκινήστε βυθίζοντας την πιπέτα μέσα στο υγρό που σκοπεύετε να αναρροφήσετε [undo]
  • Εκπαιδεύοντας τον ασθενή σας στην αυτοδιαχείριση [undo]
  • Option 2 [undo]
  • Відмовитися від ліків, оскільки я вже почуваюся краще. [undo]
  • EMB [undo]
  • Activates vasopressin receptors [undo]
  • Option 2: Only B is correct [undo]
  • Τον παρακολουθείτε για λίγες ώρες [undo]
  • Starts seeing a therapist [undo]
  • Pine tree cones [undo]
  • Trăsături [undo]
  • Permanently stop taking metformin [undo]
  • Carbimazole [undo]
  • LB [undo]
  • Mudarse a una casa nueva. [undo]
  • Definiția 2 [undo]
  • White blood cells [undo]
  • MSA [undo]
  • Observing the wrong section of the tip [undo]
  • EMB [undo]
  • Ο Κώστας έχει αναλάβει το ρόλο του πατέρα. [undo]
  • Domain 3: The "Warning Signs" [undo]
  • Start a therapy [undo]
  • Laboratory Scales I [undo]
  • To protect our clothes underneath. White is a universal colour which you can find in any country [undo]
  • Option 2 [undo]
  • Πέψη DNA με Περιοριστικές Ενδονουκλεάσες: Επιλογή του Κατάλληλου Ενζύμου [undo]
  • Semaglutide [undo]

Map: Michael Green_GEMD_1 (1115)
Node: 21100
Score:

reset

OpenLabyrinth
OpenLabyrinth is an open source educational pathway system

Review your pathway